BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 29226323)

  • 21. LASP1 promotes glioma cell proliferation and migration and is negatively regulated by miR-377-3p.
    Liu Y; Gao Y; Li D; He L; Iw L; Hao B; Chen X; Cao Y
    Biomed Pharmacother; 2018 Dec; 108():845-851. PubMed ID: 30372896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Knockdown of circular RNA circ-FARSA restricts colorectal cancer cell growth through regulation of miR-330-5p/LASP1 axis.
    Lu C; Fu L; Qian X; Dou L; Cang S
    Arch Biochem Biophys; 2020 Aug; 689():108434. PubMed ID: 32473899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B virus X protein promotes vimentin expression via LIM and SH3 domain protein 1 to facilitate epithelial-mesenchymal transition and hepatocarcinogenesis.
    You H; Yuan D; Bi Y; Zhang N; Li Q; Tu T; Wei X; Lian Q; Yu T; Kong D; Yang X; Liu X; Liu X; Kong F; Zheng K; Tang R
    Cell Commun Signal; 2021 Mar; 19(1):33. PubMed ID: 33722250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LASP2 suppresses colorectal cancer progression through JNK/p38 MAPK pathway meditated epithelial-mesenchymal transition.
    Wang B; Zhang L; Zhao L; Zhou R; Ding Y; Li G; Zhao L
    Cell Commun Signal; 2017 Jun; 15(1):21. PubMed ID: 28606091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LASP1 in Cellular Signaling and Gene Expression: More than Just a Cytoskeletal Regulator.
    Butt E; Howard CM; Raman D
    Cells; 2022 Nov; 11(23):. PubMed ID: 36497077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CSN5/JAB1 suppresses the WNT inhibitor DKK1 in colorectal cancer cells.
    Jumpertz S; Hennes T; Asare Y; Schütz AK; Bernhagen J
    Cell Signal; 2017 Jun; 34():38-46. PubMed ID: 28229932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of a unique motif in LIM mineralization protein-1 that interacts with jun activation-domain-binding protein 1.
    Sangadala S; Yoshioka K; Enyo Y; Liu Y; Titus L; Boden SD
    Mol Cell Biochem; 2014 Jan; 385(1-2):145-57. PubMed ID: 24078030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of tumor suppressor mir-203 mediates overexpression of LIM and SH3 Protein 1 (LASP1) in high-risk prostate cancer thereby increasing cell proliferation and migration.
    Hailer A; Grunewald TG; Orth M; Reiss C; Kneitz B; Spahn M; Butt E
    Oncotarget; 2014 Jun; 5(12):4144-4153. PubMed ID: 24980827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LASP1 promotes proliferation, metastasis, invasion in head and neck squamous cell carcinoma and through direct interaction with HSPA1A.
    Chen Q; Wu K; Qin X; Yu Y; Wang X; Wei K
    J Cell Mol Med; 2020 Jan; 24(2):1626-1639. PubMed ID: 31793711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LIM kinase 1 interacts with myosin-9 and alpha-actinin-4 and promotes colorectal cancer progression.
    Liao Q; Li R; Zhou R; Pan Z; Xu L; Ding Y; Zhao L
    Br J Cancer; 2017 Aug; 117(4):563-571. PubMed ID: 28664914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis.
    Wang A; Dai H; Gong Y; Zhang C; Shu J; Luo Y; Jiang Y; Liu W; Bie P
    J Exp Clin Cancer Res; 2019 Aug; 38(1):347. PubMed ID: 31395079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long non-coding RNA LINC01207 promotes prostate cancer progression by downregulating microRNA-1972 and upregulating LIM and SH3 protein 1.
    Wang S; Qiu J; Wang L; Wu Z; Zhang X; Li Q; Jiang F
    IUBMB Life; 2020 Sep; 72(9):1960-1975. PubMed ID: 32726517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An update on the LIM and SH3 domain protein 1 (LASP1): a versatile structural, signaling, and biomarker protein.
    Orth MF; Cazes A; Butt E; Grunewald TG
    Oncotarget; 2015 Jan; 6(1):26-42. PubMed ID: 25622104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-218 inhibits the proliferation, migration, and invasion and promotes apoptosis of gastric cancer cells by targeting LASP1.
    Wang LL; Wang L; Wang XY; Shang D; Yin SJ; Sun LL; Ji HB
    Tumour Biol; 2016 Nov; 37(11):15241-15252. PubMed ID: 27696291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CircIL4R activates the PI3K/AKT signaling pathway via the miR-761/TRIM29/PHLPP1 axis and promotes proliferation and metastasis in colorectal cancer.
    Jiang T; Wang H; Liu L; Song H; Zhang Y; Wang J; Liu L; Xu T; Fan R; Xu Y; Wang S; Shi L; Zheng L; Wang R; Song J
    Mol Cancer; 2021 Dec; 20(1):167. PubMed ID: 34922544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of matrix metalloproteinases (MMPs) expression and secretion in MDA-MB-231 breast cancer cells by LIM and SH3 protein 1 (LASP1).
    Endres M; Kneitz S; Orth MF; Perera RK; Zernecke A; Butt E
    Oncotarget; 2016 Sep; 7(39):64244-64259. PubMed ID: 27588391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long non-coding RNA-SNHG7 acts as a target of miR-34a to increase GALNT7 level and regulate PI3K/Akt/mTOR pathway in colorectal cancer progression.
    Li Y; Zeng C; Hu J; Pan Y; Shan Y; Liu B; Jia L
    J Hematol Oncol; 2018 Jul; 11(1):89. PubMed ID: 29970122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LINC01296/miR-26a/GALNT3 axis contributes to colorectal cancer progression by regulating O-glycosylated MUC1 via PI3K/AKT pathway.
    Liu B; Pan S; Xiao Y; Liu Q; Xu J; Jia L
    J Exp Clin Cancer Res; 2018 Dec; 37(1):316. PubMed ID: 30547804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. m6A-modified circ_0124554 promotes colorectal cancer progression and radioresistance through the miR-1184/LASP1 pathway.
    Zhong X; Peng Y; Zhang X; Peng L; Ma K; Huang Y; Yang X
    Pathol Res Pract; 2024 Jan; 253():154950. PubMed ID: 38091882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activation.
    Ji B; Feng Y; Sun Y; Ji D; Qian W; Zhang Z; Wang Q; Zhang Y; Zhang C; Sun Y
    Oncol Rep; 2018 Oct; 40(4):1885-1896. PubMed ID: 30066935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.